2026 Outstanding Abstract Achievement Award Finalists
-
Register
- Prices available after logging in
Join us for an inspiring webinar showcasing the exceptional work of this year’s finalists for the NHIA Outstanding Abstract Achievement Award. These innovative researchers and practitioners have made significant contributions to the field, addressing critical challenges and advancing best practices. During this session, each finalist will present their abstract, highlighting key findings, methodologies, and the real-world impact of their work. The award winner will be announced live at the 2026 NHIA Annual Conference in Denver, CO.
Colleen Tantalo
Nurse Manager
University of Rochester Home Infusion
I am the Nurse Manager of the University of Rochester Home Infusion Pharmacy, with 30 years of nursing experience—27 of them at the University of Rochester. My expertise spans various areas of oncology, and I am currently pursuing my doctorate. I also educate nursing students at Roberts Wesleyan University, fostering a passion for evidence-based practice and lifelong learning. Nursing has been my calling, and I encourage students to continue their education and seek innovative approaches to care. Outside of work, I am proud to have three children, one of whom has followed in my footsteps as a nurse.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Colleen Tantalo has no relevant financial relationships with ineligible companies to disclose.
Kelly Yu
Pharmacy Resident
KabaFusion
Kelly obtained her Doctor of Pharmacy degree from The University of Texas at Austin in 2025 after completing a Bachelor’s of Science and Arts in Nutritional Sciences. Prior to her residency, she gained experience in home infusions as a pharmacy technician where she developed an appreciation for ambulatory care and specialized pharmacy services. Kelly chose to pursue a PGY1 with KabaFusion because of its longitudinal ambulatory care focus and strong emphasis in transitions of care and nutrition support.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Kelly Yu has no relevant financial relationships with ineligible companies to disclose.
Lisa Kinder, RD, CNSC
Clinical Program Manager
Optum Infusion Pharmacy
Lisa Kinder is a registered dietitian, maintains certification as a nutrition support clinician, and has worked in the home infusion setting since 2004. She is a clinical nutrition program manager at Optum Infusion Pharmacy. Her current role focuses on training and education programs for clinicians providing home parenteral nutrition. She is passionate in the areas of safe parenteral nutrition initiation in the home setting and the prevention of refeeding syndrome. Lisa has co-authored publications including abstracts, continuing education articles, a white paper, and has presented posters and educational sessions at national conferences including ASPEN and NHIA. She serves on NHIA’s Education Committee. Lisa received UnitedHealth Group’s Sages of Clinical Services Award in 2019, is a member of the home nutrition support team that was honored with ASPEN’s Clinical Nutrition Team of Distinction Award in 2022, received ASPEN’s HPEN Trailblazer Award in 2023 and became a NHIA Fellow in 2025.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Lisa Kinder has no relevant financial relationships with ineligible companies to disclose.
Edward OBryan, MD, MBA, CPE
Chief Medical Officer
CSI Pharmacy
Dr. O’Bryan serves as Chief Medical Officer at CSI Pharmacy. His role is essential at CSI, where he ensures that patients with rare and chronic diseases can access life‑changing care. He also oversees the organization’s clinical research program and serves as the Principal Investigator for numerous clinical studies. Dr. O’Bryan is a seasoned physician entrepreneur who has founded several successful healthcare companies and non-profits over his 20+ years in the healthcare space. Previously, Dr. O’Bryan served as Chief Medical Officer and Vice President of Clinical Operations for TruePill, a telehealth, digital pharmacy, and digital diagnostics company. Academically, Dr. O’Bryan maintains his position as an Associate Professor of Medicine at the Medical University of South Carolins (MUSC). He has over $15 million dollars in funded research and numerous publications and academic presentations in addition to AOA honors. He attended Davidson College, received his M.D. from MUSC, and his M.B.A. from the University of Tennessee.
NHIA Requires planners, faculty, and others who affect the content of this activity to disclose all financial relationships they have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to policy.
Edward O'Bryan has no relevant financial relationships with ineligible companies to disclose.